Movement Alert|Innoscience Falls 3.5% in Regular Trading, Director and Institutional Shareholder Selling Continues to Pressure Stock

Market Focus06-26

On June 26, Innoscience fell 3.5% in regular trading, trading at HKD 63.95/share, with turnover of HKD 150 million. The stock has now declined for three consecutive trading sessions, significantly underperforming the semiconductor sector.

On the news front, company director Luo Weiwei sold approximately 289,000 shares on June 10 and 11, while China Merchants Bank and its subsidiary CMBI-related entities cumulatively reduced their long positions by approximately 1.49 million shares in early June. The company remains in a loss-making stage, and multiple rounds of shareholder disposals have continued to suppress market sentiment.

Additionally, on June 3 the company completed H-share full circulation, converting approximately 373.8 million domestically unlisted shares into tradeable H shares, increasing listed H shares from 525.5 million to 899.4 million. The expanded tradeable float has amplified selling pressure. Within the semiconductor sector today, SMIC fell 2.79%, GigaDevice fell 3.25%, Montage Technology fell 5.71%, and Iluvatar CoreX fell 5.93%, reflecting broad sector weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment